These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 29879685

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.
    Nherera L, Marks D, Minhas R, Thorogood M, Humphries SE.
    Heart; 2011 Jul; 97(14):1175-81. PubMed ID: 21685482
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.
    Pelczarska A, Jakubczyk M, Jakubiak-Lasocka J, Banach M, Myśliwiec M, Gruchała M, Niewada M.
    Atherosclerosis; 2018 Mar; 270():132-138. PubMed ID: 29407882
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic diagnosis of familial hypercholesterolaemia using a rapid biochip array assay for 40 common LDLR, APOB and PCSK9 mutations.
    Martin R, Latten M, Hart P, Murray H, Bailie DA, Crockard M, Lamont J, Fitzgerald P, Graham CA.
    Atherosclerosis; 2016 Nov; 254():8-13. PubMed ID: 27680772
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
    Ontario Health (Quality) .
    Ont Health Technol Assess Ser; 2022 Nov; 22(3):1-155. PubMed ID: 36158868
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia.
    Chan DC, Pang J, Hooper AJ, Bell DA, Bates TR, Burnett JR, Watts GF.
    J Clin Endocrinol Metab; 2018 Apr 01; 103(4):1704-1714. PubMed ID: 29408959
    [Abstract] [Full Text] [Related]

  • 14. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
    Hsiung YC, Lin PC, Chen CS, Tung YC, Yang WS, Chen PL, Su TC.
    Atherosclerosis; 2018 Oct 01; 277():440-447. PubMed ID: 30270083
    [Abstract] [Full Text] [Related]

  • 15. Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
    Benedek P, Jiao H, Duvefelt K, Skoog T, Linde M, Kiviluoma P, Kere J, Eriksson M, Angelin B.
    J Intern Med; 2021 Aug 01; 290(2):404-415. PubMed ID: 33955087
    [Abstract] [Full Text] [Related]

  • 16. Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.
    Campbell-Salome G, Jones LK, Masnick MF, Walton NA, Ahmed CD, Buchanan AH, Brangan A, Esplin ED, Kann DG, Ladd IG, Kelly MA, Kindt I, Kirchner HL, McGowan MP, McMinn MN, Morales A, Myers KD, Oetjens MT, Rahm AK, Schmidlen TJ, Sheldon A, Simmons E, Snir M, Strande NT, Walters NL, Wilemon K, Williams MS, Gidding SS, Sturm AC.
    Circ Genom Precis Med; 2021 Feb 01; 14(1):e003120. PubMed ID: 33480803
    [Abstract] [Full Text] [Related]

  • 17. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.
    Brett T, Qureshi N, Gidding S, Watts GF.
    Atherosclerosis; 2018 Oct 01; 277():399-406. PubMed ID: 30270077
    [Abstract] [Full Text] [Related]

  • 18. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH, Kim NT, Nguyen MNT, Pang J, Hooper AJ, Watts GF, Do DL.
    Atherosclerosis; 2018 Oct 01; 277():392-398. PubMed ID: 30270076
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.